Mazón-González B, Olguín-Cruces VA

Language: Spanish
References: 23
Page: 26-33
PDF size: 300.24 Kb.

ABSTRACT

Background: Some studies have been realized to know the concordance level between the preoperative and the diagnosis of endometrial cancer and it has been observed that there is a tendency to undergrade the stage of cancer in preoperative studies.
Methods: It was carried out an observational, retrolective, transversal and comparative study to establish the concordance between the preoperative and the definitive study in endometrial cancer. We revised the records of the Pathology department of the Hospital “Luis Castelazo Ayala” from January 1st, 2012, to December 31th, 2014. The concordance was calculated by using the Cohen’s kappa coefficient and the force scale of concordance proposed by Byrt, and the test of comparison of two proportions.
Results: We observed a low concordance between the preoperative and the definitive study regarding the histologic variety (kappa = 0.258, p = 0.000) and the degree of differentiation (kappa = 0.220, p = 0.001). These differences were statistically significant for the moderate grade degree of differentiation (Z = −3.409, p ‹ 0.05).
Conclusion: There is a low level of concordance between the preoperative and the definitive study in the diagnosis of endometrial cancer.

REFERENCES

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121.

2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166.

3. Secretaría de Salud. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. México: Dirección General de Epidemiología, Secretaría de Salud; 2003.

4. Ruvalcaba-Limón E, Cantú-de León D, León-Rodríguez E, Cortés-Esteban P, Serrano-Olvera A, Morales- Vásquez F, et al. Primer Consenso Mexicano de CE. Grupo de Investigación en Cáncer de ovario y tumores ginecológicos de México (GICOM). Rev Invest Clin. 2010; 62 (6): 585-605.

5. Leslie KK, Thiel KW, Goodheart MJ, De Geest K, Jia Y, Yang S. Endometrial Cancer. Obstetrics and Gynecology Clinics of North America. 2012;39(2): 255-68.

6. Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP et al. Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control. 2010 Nov;21(11):1851-6. doi: 10.1007/s10552-010-9612-8.

7. American College of Obstetricians and Gynecologists (ACOG). ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005 Aug;106(2):413-25.

8. Werner HM, Trovik J, Marcickiewickz J, Tingulstad S, Staff AC, Engh ME, et al. A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis. Eur J Cancer. 2013 Feb;49(3):625-32. doi: 10.1016/j.ejca.2012.09.006.

9. Leitao MM Jr, Kehoe S, Barakat RR, Alektiar K, Gattoc LP, Rabbitt C, et al. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol. 2008 Nov;111(2):244-8.

10. Mitchard J, Hirschowitz L. Concordance of FIGO grade of endometrial adenocarcinomas in biopsy and hysterectomy specimens. Histopathology. 2003 Apr;42(4):372-8.

11. Thanachaiviwat A, Thirapakawong C, Leelaphatanadit C, Chuangsuwanich T. Accuracy of preoperative curettage in determining tumor type and grade in endometrial cancer. J Med Assoc Thai. 2011 Jul; 94(7):766-71.

12. Mavromatis ID, Antonopoulos CN, Matsoukis IL, Frangos CC, Shalkidou A, Creatsas G, et al. Validity of intraoperative gross examination of myometrial invasion in patients with endometrial cancer: a meta-analysis. Acta Obstet Gynecol Scand. 2012 Jul;91(7):779-93.

13. Case AS, Rocconi RP, Straughn JM, Conner M, Novak L, Wang W et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol. 2006 Dec;108(6):1375-9.

14. Egle D, Grissemann B, Zeimet AG, Müller-Holzner E, Marth C. Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinoma. Gynecol Oncol. 2008 Sep;110(3):286-92.

15. Hoekstra A, Singh D, Garb M, Arekapudi S, Rademaker A, Lurain JR. Participation of the general gynecologist in surgical staging of endometrial cancer: Analysis of cost and perioperative outcomes. Gynecol Oncol. 2006 Dec;103(3):897-901.

16. Zeferino-Toquero M, Bañuelos-Flores J, Maytorena- Córdova G, Reyna-Anaya H, Acevedo-Vega MF. Incidencia de CE en pacientes con biopsia preoperatoria de hiperplasia endometrial. Ginecol Obstet Mex 2013;81:519-24.

17. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S105-43.

18. Secretaría de Salud. Guía de práctica clínica diagóstico y tratamiento del Cáncer de endometrio. México: Secretaría de Salud; 2010.

19. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2009 May;105(2):103-4.

20. Byrt T, Bishop J, Carlin JB. Bias, Prevalence and Kappa. Clin Epidemiol.1993; 46:423-9.

21. Bilgin T, Ozuysal S, Ozan H, Atakan T. Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia. J Obtet Gynaecol Res. 2004;30:205-9.

22. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125-36. doi: 10.1016/ S0140-6736(08)61766-3.

23. May K, Bryant A, Dickinson HO, Kehoe S, Morrison. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007585. doi: 10.1002/14651858. CD007585.pub2.